Photocatalytic Oxidation of Carbofuran Pesticide Using Zinc Oxide

In recent years, the application of ultraviolet irradiation and zinc oxide (UV/ZnO) process water and wastewater treatment has gained removal activity of the persistence organic compounds. The degradation of carbofuran pesticide was investigated under ultraviolet irradiation and zinc oxide (UV/ZnO) process. Likewise, the effect of the operational parameters such as reaction volume, initial concentration of catalyst, initial carbofuran concentration, light intensity and pH were studied. In this study the (UV/ZnO) process at different initial concentrations (50-250 mg/L), 5 different initial pH and 5 different initial concentration of catalyst was investigated. Analyses were performed by gas chromatography mass spectroscopy. Results showed that the carbofuran initial concentration of 50 mg/L, ZnO concentration of 300 mg/L, pH of 8, light intensity of 125 watts and reaction volume of 150 mL, were the optimum condition for degradation of carbofuran by UV/ZnO system. This study demonstrated that carbofuran could be effectively degraded by ultrasonic irradiation

Performance evaluation of a scoria-compost biofilter treating xylene vapors

The removal of xylene vapors was studied in a biofilter packed with a new hybrid (scoria/compost) packing material at various inlet loads (IL) and empty bed residence times (EBRT) of 90, 60, and 40s. The best performance was observed for EBRT of 90s, where a removal efficiency of 98% was obtained under steady state condition for inlet xylene concentration of 1.34 g m(-3), while a maximum elimination capacity of 97.5 g m(-3) h(-1) was observed for IL of 199.5 g m(-3) h(-1). Carbon dioxide production rates and the microbial counts for xylene-degraders followed xylene elimination capacities. Overall look to the results of this study indicates that the scoria/compost mixture could be considered as a potential biofilter carrier, with low pressure drop (here <4 mm H2O), to treat air streams containing VOCs

Degradation of Cyanide using Stabilized S, N-TiO2 Nanoparticles by Visible and Sun Light

In this paper, cyanide degradation (at pH12) using S, N-TiO2 photo-catalyst, synthesized by sol-gel method, stabilizedon glass microbeads and scoria stones were investigated. The main raw materials were thiourea (Tu) as a source of S and N and tetra butyl orthotitanate (TBOT). The effects of S and N amount, visible and sun light, irradiation time and different initial cyanide concentrations (50, 100, 200 and 300 mg/L) on destruction of cyanide were studied. The S, N-TiO2 film with 0.25 g thiourea showed the best cyanide destruction in visible light. The results showed that cyanide (50 mg/L) was destructed up to 94% in visible light and approximately 100% in sun light by S, N-TiO2/glass microbead. The results also indicated 85% and 94% destruction in visible and sun light respectively by S, N-TiO2/scoria stone within 4 h. Finally, the S, N-TiO2 stabilized on glass microbeads can be effectively implemented as a new method for treatment of wastewater containing free cyanide under sun light

The Effect of Dust Storm on the Microbial Quality of Ambient Air in Sanandaj: A City Located in the West of Iran.

BACKGROUND & AIMS: The presence of pathogenic microorganisms in the dust storm can cause diseases such as Asthma, Pneumonia, and respiratory infections. The aim of this study was to determine the relationship between air-borne particles with airborne microorganisms in normal and dusty days in Sanandaj, a city located in the west of Iran. MATERIALS & METHODS: Air sampling was conducted during the normal and dusty days through Andersen single-stage impactor (28.3 L/min) for 2.5 min. Air particles concentration (PM10) was measured daily and microbial sampling was also conducted on every six days and on the dusty days. Finally, the data was analyzed by SPSS-16 (ANOVA and paired T-tests). RESULTS: The concentration of airborne microorganisms (bacteria and fungi) was increased by an increase of the airborne particles. Particles concentration in May, June and July (twice per month) was more than of the standard value. The predominant species of bacteria and fungi during the occurrence of Dust storm was Bacillus spp. (56.2% of total bacteria) and Mycosporium spp. (28.6% of total fungi), respectively. DISCUSSION AND CONCLUSION: The results showed that the number of airborne microorganisms (bacteria and fungi) increased during the dust storm. Therefore, the microorganisms in the dust storm can cause biological harmful effects on human health

Biosorption of lead using Penicillium notatum dead biomass from aqueous solutions

Lead is one of the stable and biodegradable pollutants released from industrial, agricultural and technological development activities more than the permitted level in the environment. This metal, due to its toxicity, even at low concentrations, has adverse effects on the environment and health of living organisms. The aim of this study is to investigate the bio-absorption of lead by the fungus Penicillium notatum in aqueous solutions. For this purpose, the fungus Penicillium notatum PTCC 5074 was prepared from the Iranian Scientific Research Organization as lyophilisation and to culture and reproduce it in the culture medium of potato dextrose agar and sabouraud dextrose broth. In this study, the effect of some parameters such as lead concentration, ion intensity, biomass concentration, temperature and contact time on the rate of adsorption of lead by abiotic biomass at pH = 5 were evaluated. The maximum absorption rate was 180.75 mg g(-1) under optimal conditions (concentration of metal = 228 mg L-1, ion intensity = 43.2 mg L-1 Ca2+, biomass concentration = 1.2 g L-1 of dry weight of biomass, temperature = 33 degrees C, and contact time = 105 min). Absorption data were better fitted by Langmuir model R-2 = 0.9820). Also, due to the thermodynamic constants, it was found that lead absorption process is thermally abiotic by a biomass. Gibbs free energy values (Delta G) showed that all absorption processes are spontaneous and physical. The false quadratic equation (R-2 = 1) has the best compatibility with regard to kinetic data. BET, SEM and EDX tests were also used to determine the biomass characteristics

Evaluation of NPP1 as a novel biomarker of coronary artery disease: A pilot study in human beings

Purpose: Coronary artery calcification (CAC) is utilized as an important tool for global risk assessment of cardiovascular events in individuals with intermediate risk. Ecto phosphodiesterase/nucleotide phosphohydrolase-1(ENPP1) converts extracellular nucleotides into inorganic pyrophosphate and it is a key regulator of tissue calcification that adjusts calcification in tissues like vascular smooth muscle cells. The main purpose of this clinical study was to find out the correlation between ENPP1 serum concentration and CAC in human for the first time. Methods: In this study 83 patients (16 diabetic patients and 67 non-diabetic patients) with coronary artery disease who fulfilled inclusion and exclusion criteria, entered the study. For all patients a questionnaire consisting demographic data and traditional cardiovascular risk factors were completed. Computed tomography (CT)-Angiography was carried out to determine coronary artery calcium score and enzyme-linked immunosorbent assay (ELISA) method was used for measuring ENPP1 serum concentrations. Results: There was a reverse significant correlation between ENPP1 serum concentration and total CAC score and also CAC of right coronary artery (RCA) (P < 0.05) in non-diabetic patients. Conclusion: On the basis of our results, ENPP1 serum concentration may be a suitable biomarker for coronary artery disease at least in non-diabetic patients. However, more studies with higher sample size are necessary for its confirmation. © 2018 The Authors

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods: Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15–39 years to define adolescents and young adults. Findings: There were 1·19 million (95% UI 1·11–1·28) incident cancer cases and 396 000 (370 000–425 000) deaths due to cancer among people aged 15–39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5–65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8–57·9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9–15·6] per 100 000 person-years) and middle SDI (13·6 [12·6–14·8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9–25·2) DALYs to the global burden of disease, of which 2·7% (1·9–3·6) came from YLDs and 97·3% (96·4–98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation: Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Funding: Bill &amp; Melinda Gates Foundation, American Lebanese Syrian Associated Charities, St Baldrick's Foundation, and the National Cancer Institute

Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached$8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total,$40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this,$13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and$1.4 billion was repurposed from existing health projects. $3.1 billion (22.4$2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7$1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Interpretation: By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe